ATTD 2011 Yearbook 2012
DOI: 10.1002/9781118321508.ch12
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes Technology and the Human Factor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 8 publications
0
11
0
Order By: Relevance
“…Liberman et al 25 presented a review of recently published articles (within the last year) on issues affecting the ''human factor,'' including decreased adherence, lack of motivation, and low QoL. Eleven articles were included, each summarized and commented on by the review authors.…”
Section: Ap/closed-loop-specific Studiesmentioning
confidence: 99%
“…Liberman et al 25 presented a review of recently published articles (within the last year) on issues affecting the ''human factor,'' including decreased adherence, lack of motivation, and low QoL. Eleven articles were included, each summarized and commented on by the review authors.…”
Section: Ap/closed-loop-specific Studiesmentioning
confidence: 99%
“…Insulin pump therapy has become a popular method for insulin delivery in young people with diabetes [ 2 , 3 ]. However, this therapy involves mastering many functions that some families find difficult [ 4 ]. Adapting a multidisciplinary approach, intensifying education, and establishing close follow-up can result in alleviating these difficulties [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Insulin pumps are equipped with various advanced functions for insulin delivery. However, despite the advances seen in diabetes treatment, the technology has not been as well established as expected, and a specific group of patients has found its application difficult [ 4 ]. Accordingly, proper education and understanding are crucial.…”
Section: Introductionmentioning
confidence: 99%
“…Other studies do not consistently demonstrate that the use of CSII alone improves HbA1c when compared with MDI in children [16]. In one study, utilizing a CGM decreased the amount of time spent in hypoglycemia and hyperglycemia in adults 25 years and older and a decreased amount of time spent in hypoglycemia in [15][16][17][18][19][20][21][22][23][24] year olds but it failed to show a substantial change in 8-14 year olds. Additionally, CGM use tended to decrease over time in both the 8-14 year olds and 15-24 year old age groups from 7 days/week to 3.3 and 3.7 days/week respectively after 6 months [17].…”
Section: Current Therapeutic Optionsmentioning
confidence: 97%